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Ancillary Imaging Tests for 
Confirmation of Brain Death
Sudharsana Rao Ande and Jai Jai Shiva Shankar
Abstract
Brain death is an irreversible termination of functions of the entire brain including 
brain stem. The American Association of Neurology has defined brain death with 
three cardinal criteria, namely cessation of the functions of brain including brain 
stem, coma or unresponsiveness, and apnea. Ancillary testing is done in situa-
tions where clinical criteria of brain death cannot be determined by neurological 
examination or by apnea test. Ancillary tests for determining brain death can be 
primarily divided into two groups. One group includes tests that can test brain’s 
electrical functions and the other group includes tests that can document cerebral 
blood flow in the brain on imaging. In this chapter, we present characteristics of the 
ideal ancillary test in the diagnosis of brain death and also describe various types of 
ancillary imaging tests used in the clinical setting for brain death determination and 
the merits and demerits associated with these techniques.
Keywords: brain death, ancillary imaging test, brainstem function, computed 
tomography, DSA, nuclear scintigraphy, CT perfusion (CTP), CT angiography 
(CTA), magnetic resonance imaging (MRI), magnetic resonance angiography 
(MRA), magnetic resonance perfusion (MRP)
1. Introduction
Brain death is defined as permanent cessation of all vital functions of the brain. 
It is principally established using clinical criteria including coma, absence of brain 
stem reflexes, and using apnea test. In Canada, two physicians must determine 
whether particular patient is brain dead or not [1, 2]. The criteria for declaring brain 
death includes deep unresponsive coma with established etiology, absence of revers-
ible conditions [2]. Absence of brain stem reflexes includes absence of gag, cough, 
bilateral absence of corneal response, pupillary response to light and vestibule-
ocular response, absence of respiratory efforts based on apnea test, and absence of 
confounding factors [2]. Ancillary imaging tests are necessary in situations when 
neurological examination or the apnea test cannot be performed or its validity comes 
into a question [3]. These situations include when patients have resuscitated shock, 
hypothermia, severe metabolic abnormalities, complex spinal reflexes, peripheral 
nerve or muscular dysfunctions, high cervical spine injury, craniofacial trauma or if 
the patient is on sedative drugs such as alcohol, barbiturates, sedatives, and hypnotics.
An ideal ancillary test should not have any false positive results. This is very 
important in brain death patients. If the ancillary test confirms death, when in 
fact, patient is not dead, is very dangerous and raises critical social, ethical and 
legal concerns. The main objective of the ancillary test would be to demonstrate 
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the absence of cerebral electric activity or cerebral circulatory arrest [4]. Based on 
this, the first type assesses the electrical functions of the brain, and the other type 
analyses cerebral blood flow in the brain on imaging. Here, we provide description 
of cerebral blood flow imaging techniques and compare them.
2. Characteristics of ideal ancillary test for determining the brain death
Young and his colleagues described the attributes of an ideal ancillary test [5]. A 
reliable ancillary test should meet all the criteria mentioned below.
1. When the test confirms brain death, there should be no one that recovers or 
have the potential to recover. There should be no false positives.
2. The test should be independently sufficient enough to establish whether brain 
death is present or not.
3. The test should not be susceptible to external or internal confounding factors 
such as drug effects and metabolic disturbances.
4. The test should have standardized technology, technique, and classification of 
results.
5. The test should be inexpensive, safe, and readily applied. Testing should not 
be restricted to only few tertiary academic centers. It could be applied with any 
intensive care unit, and the technique should be mastered without difficulty.
3. Ancillary imaging tests used in brain death determination
3.1 Digital subtraction angiography (DSA)
This is considered the gold standard for ancillary imaging test. DSA is the first 
used modality for determining the cerebral blood flow. It is typically performed with 
a catheter tip in the aortic arch and contrast injection into each of the four arteries 
supplying the brain [3]. At least two injections, 20 min apart, must show an absence 
of filling of four arteries as their course becomes intracranial (Figure 1) [3, 6].
This test is capable of detecting dynamic blood flow in the arteries, veins, and 
capillaries. The criteria for brain death diagnosis using this method include no 
intracerebral filling at the level of entry into the skull of carotid or vertebral artery 
and filling of external carotid arteries. But this method does not have the spatial 
resolution to distinguish the blood flow in the different parts of the brain such as 
brainstem. Other disadvantages include transportation of patents to the angio suite; 
requires expert operator to perform; is invasive; and requires injection of contrast 
medium that may have a potential risk to the patients with kidney diseases. It can 
have “stasis filling” due to diffusion of contrast in the static column of blood, which 
can result in false negatives. Thus, it is an expensive procedure and not readily avail-
able in many hospitals and may not be easy to interpret in many healthcare facilities.
3.2 Nuclear scintigraphy
This is another gold standard ancillary imaging test for determination of brain 
death. In this technique, a gamma emitting radioactive tracer is intravenously 
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injected and is detected by a radio counter in the nuclear medicine. One of the 
radioactive tracers used is Tc99m-DTPA. After bolus intravenous injection of 
the tracer, brain vascular flow is estimated. DTPA does not have the ability to 
cross the intact blood brain barrier, so intracranial blood flow is seen in normal 
patients. However, Tc99m-DTPA tracer has low resolution for brain vascular 
flow [7]. There are two other radiopharmaceuticals, namely Tc99m-HMPAO 
(hexamethylpropyleneamine oxime) and Tc99m-ECD (ethyl cysteinate dimer) 
[8]. Both of them are brain specific, lipophilic and after intravenous injection, 
they cross the blood brain barrier. Because of this property, they are accumu-
lated proportional to the blood flow in normal gray matter including brain cells 
of cerebrum, cerebellum, and brainstem [8]. So, it is not only blood flow but 
also brain parenchyma is seen in the normal functioning brain. In this method, 
radioactive isotope is injected 30 min after its reconstitution. Images are taken 
immediately after injection, after 30 min, and finally after 2 hours. If there is no 
blood flow, there is no accumulation of tracer in the brain and brain looks hollow, 
this phenomenon is known as “hollow skull” or “empty bulb” sign (Figure 2). 
These injected radioactive tracer compounds are safe to the patients because they 
do not interact with their medication and have no associated side effects [8].
Disadvantages of this technique is sometimes posterior fossa may be difficult to 
visualize, and uptake may be affected by hypothermia and barbiturates [3]. It does 
not have the spatial resolution to detect isolated brainstem activity. Other disad-
vantages include associated time delay and availability of this technique. Nuclear 
Figure 1. 
Digital subtraction angiography image of a brain dead patient showing no intracranial filling on selective (A) 
left and (B) right common carotid artery as well as (C) left and (D) right vertebral artery angiograms. These 
show continued filling of the extracranial arteries including (A) left and (B) right external carotid arteries.
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scintigraphy requires instrumentation, an experienced radiologist to interpret the 
test results, and the radioactive tracer used in this test is expensive and requires a 
trained pharmacist to reconstitute.
3.3 CT head
Computed tomography (CT) was introduced in 1970, since then it has revolu-
tionized the assessment of head injuries including brain death [9]. It is fast, readily 
available, and requires no contrast medium. It is a standard imaging test for the 
patients admitted in the hospital because of brain injuries. Plain head CT scan can 
visualize brain tissue and lesion. It accurately diagnoses skull fractures, intracranial 
bleeds, brain contusions, and brain herniation. For diagnosis of brain death, a dif-
fuse loss of gray-white mater differentiation needs to be established (Figure 3).
Plain head CT has several limitations in assessment of brain death. Plain head 
CT does not provide functional information of the brain and does not assess 
Figure 2. 
“Hallow skull”/“empty bulb” sign shown in brain death patient using (A) AP and (B) lateral nuclear 
scintigraphy imaging. Flow and delayed imaging demonstrated no significant intracranial flow or parenchymal 
uptake.
Figure 3. 
Plain head CT image of a brain dead patient showing diffuse loss of gray-white mater differentiation.
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intracranial blood flow. Diffuse loss of gray-white mater differentiation is likely a 
late phenomenon and the inter-rater reliability is poor [10].
Contrast enhanced CT of head can be acquired to assess brain blood flow 
but is delayed compared to CT angiography. Contrast-enhanced CT acquisition 
requires a delay of 5 min, whereas CT angiography requires only 12–16 seconds. 
This delay makes the contrast-enhanced CT highly susceptible to “stasis filling” 
of the brain blood vessels. Thus, plain head CT is not very reliable test in deter-
mining brain death.
3.4 Computed tomography angiography (CTA)
CTA is a valuable ancillary imaging technique for intracranial blood flow. CTA 
was first reported in 1998 as an ancillary test in diagnosing the brain death [11]. 
According to Dupas et al., in 14 patients who were diagnosed as brain dead using 
clinical criteria, the results were confirmed to have 100% sensitivity using CTA 
[11]. CTA is fast, non-invasive, technically noncomplicated, inexpensive, readily 
and widely available. It is perhaps the most widely available brain blood-flow test. 
CTA has a high spatiotemporal resolution and is relatively operator independent. 
Several European countries have adopted CTA as an ancillary test but not the United 
States [12, 13].
The technique of CTA involves rapid intravenous administration of iodinated 
contrast followed by volume scanning of the whole brain. For imaging of brain 
death at least two acquisitions should be performed, 60 seconds apart [9]. Others 
have proposed at least three acquisitions-arterial phase scanning after 20 seconds 
and venous phase scanning after 50–60 seconds [4].
Diagnostic criteria for brain death using CTA include lack of intracranial arterial 
contrast opacification. Lack of intracranial contrast opacification can be assessed by 
4, 7, and 10 point scales. In 4 point scale, M4 (cortical) segments of middle cerebral 
artery (MCA) and intracerebral vein (ICV) are evaluated for contrast opacification 
[11]. The 7 point scale included evaluation of MCA-M4, anterior cerebral artery 
(ACA), ICV, and great cerebral vein (GCV) [14]. In the 10 point scale, all the seven 
segments of the 7 point scale plus posterior cerebral artery (PCA) and basilar artery 
are included [6]. In a recent study, Garret et al. assessed statistical performance of 
CTA in diagnosing brain death. For all the 18 patients included in the study, CTA 
had sensitivity of 75%, specificity of 100%, positive predictive value of 100%, and 
negative predictive value of 33% [15]. Another recent study from Macdonald et al. 
reported the diagnostic accuracy and inter-rater reliability of different ancillary 
imaging tests used for brain death in 74 patients. They showed that CTA along with 
CTP and radionuclide scan had a specificity and positive predictive value of 100% 
[10]. These results certainly add to the growing medical literature that supports 
the use of CTA as a reliable ancillary imaging test in confirming the brain death. 
However, systematic reviews do not support use of CTA as an ancillary imaging test 
for confirmation of brain death [16, 17].
The disadvantages of CTA are that this is not widely available as a bedside 
test and patient needs to be transported to imaging facility and this is challeng-
ing for an intensive care unit (ICU) patient. However, this can be obviated by 
the use of portable CT scanners in the future. CTA provides incomplete quanti-
tative measurement of cerebral blood flow due predominantly of “stasis filling” 
(Figure 4). It is defined as delayed, weak persistent opacification of proximal 
cerebral arteries. This phenomenon causes a major problem in the development 
of reliable CTA protocol for the diagnosis of brain death [6]. There is also poten-
tial risk of damage to the organs of the brain death patients because of iodinated 
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contrast media used in CTA. However based on the volume of contrast used for 
CTA, this is rare or negligible [18, 19].
3.5 Computed tomography perfusion (CTP)
CTP is an advanced CT scan technique that provides both anatomical as well as 
functional information about the brain. CTP is useful in detecting perfusion even 
in small vessels such as arterioles, capillaries, and venules [20]. CTP is routinely 
used for evaluation of cerebral ischemia and vascularization of brain tumors and 
has the spatial resolution to quantify perfusion in any selected part of the brain [21, 
22]. This imaging technique can help in calculation of cerebral blood flow (CBF) 
and cerebral blood volume (CBV). Normal CBF in the brain is 50–60 ml/100 mg/
min and CTP can measure as low as 1.2 ml/100 mg/min [20]. CTP is very sensitive 
in detecting the blood flow and can detect decreased perfusion as low as 2–3% in 
CBF and 2% in CBV [23]. In CTP acquisition protocol, patients will undergo whole 
brain coverage with 80 kVp, 100 mAs resulting in a radiation dose of approximately 
CT dose index of 189.64 mGy [20]. A minimum scan duration of 60 seconds is 
recommended to reliably cover the venous phase of the circulation. A total of 40 ml 
nonionic iodinated contrast medium injected at the rate of 5 ml/seconds, followed 
by 40 ml of saline flush at the rate of 5 ml/seconds. Regular perfusion analysis 
is performed if intracranial arteries are seen on the source images [20]. Whole 
brain death could be seen as no intracranial CBF or CBV (Figure 5). Shankar et al. 
compared CTP and CTA derived from the CTP for confirmation of brain death 
in a retrospective review of 11 patients clinically suspected of brain death [20]. 
CTA showed a sensitivity of 72.7% for 7- and 4-point scales, 81.8% sensitivity for 
opacification of ICV, and 100% sensitivity for CTP scores in the brainstem [20]. 
They, for the first time, showed that CTP can be a valuable ancillary tool in early 
detection of brain death. Recently, Sawicki et al. tested the reliability and diagnostic 
accuracy of CTP over CTA in determining brain death [24]. For whole brain CTP, 
Figure 4. 
Axial CTA images (A, B) in patient with clinically confirmed brain death show contrast opacification of 
bilateral internal carotid arteries, proximal branches of bilateral middle, and anterior cerebral arteries. None 
of the two images show opacification of M4 or cortical branches of middle cerebral arteries, distal anterior 
cerebral artery (ACA), internal and great cerebral vein. There is some opacification of only right posterior 
cerebral artery. There is continued filling of the extra cranial arteries.
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they also showed a sensitivity of 100% to confirm the diagnosis of brain death [24]. 
MacDonald et al. showed similar sensitivity [10].
CTP can also evaluate brain-stem specific CBF [10, 20]. The concept of isolated 
brainstem death was first proposed by Shankar et al. in clinically confirmed brain 
death patients (Figure 6) [20]. Exact pathophysiological mechanism behind 
isolated brainstem death is not yet known. This is described when in patients with 
Figure 5. 
CT perfusion showing no detectable cerebral blood flow (CBF) (A) and cerebral blood volume (CBV) (B) in 
the whole brain.
Figure 6. 
CT perfusion showing matched defect on cerebral blood flow (CBF) (A and B) and cerebral blood volume 
(CBV) (C and D) maps in brainstem only. The supratentorial brain as well as cerebellum showed preserved 
CBF and CBV.
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clinically confirmed brain death, there is presence of blood flow in the supratento-
rial brain and isolated absence of blood flow in the brainstem [10, 20]. Clinical 
examination does not differentiate between whole brain death and isolated brain-
stem death. CTP is the first imaging test reported to show the phenomenon of 
isolated brainstem death [10, 20]. It is suspected that isolated brainstem death is an 
earlier phenomenon in the process of brain death and may help early declaration of 
brain death [10]. However, the concept of brainstem death is debatable at the pres-
ent time, and more studies are needed to establish this phenomenon.
Like CTA, CTP is a widely available tool and with the availability of automated 
software, CTP is relatively operator-independent [20]. The advantage of CTP is that 
it can be performed along with CTA. CTP has a presumed risk of contrast induced 
renal damage in the patients with kidney disease. But, based on the volume of con-
trast used for CTP, the chances of nephrotoxicity is very rare or negligible [18, 19].
3.6 Magnetic resonance imaging (MRI)
It is a reliable high-resolution imaging of brain and has been used for imag-
ing for brain death. MRI has an advantage of not requiring nephrotoxic contrast 
material for demonstration of cerebral blood flow. It is noninvasive and accurate in 
identifying structural abnormalities in the brain. Common MRI findings in brain 
death patients are variable edema, diffuse cortical high signal intensity, diffuse 
cerebral white matter injury, and tonsillar herniation [25, 26]. Lovblad and col-
leagues demonstrated the usefulness of diffusion weighted imaging (DWI) in the 
diagnosis of brain death [27]. They reported that apparent diffusion coefficient 
(ADC) values are reduced in brain death patients when compared to the normal 
individuals [27]. Using DWI and ADC mapping, it is possible to identify areas of 
cytotoxic damage and ischemic damage [4]. However, this has not been accepted in 
the imaging guidelines for brain death. The major disadvantages of this method are 
the length of the scan time and obtaining MRI on ventilated patients as they may 
have several contraindications to MRI.
3.7 Magnetic resonance angiography (MRA)
It is a reliable test for cerebral blood flow [28] and can detect intracranial arterial 
blood flow and flow voids (Figure 7). However, MRA has not yet been proven as an 
ancillary test in assessing the brain death. Time of flight MRA is relatively immune 
to “stasis filling” when compared to CTA or DSA. Like any MRI, the patient needs 
Figure 7. 
Time of flight MR angiography image of a brain dead patient showed no intracranial flow but preserved 
extracranial flow on source image (A), axial (B), and coronal (C) maximum intensity projection images.
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transportation to the radiology department, and the length of time for MRA is 
longer than that for CTA or CTP. There is requirement of having specialized critical 
care equipment in a scanner.
3.8 Magnetic resonance perfusion (MR perfusion)
MRP is noninvasive and can be used to detect intracranial arterial blood flow. 
It can also detect perfusion parameters of affected brain tissues such as cerebral 
blood flow and cerebral blood volume. There are not many reports in the literature 
that used MR perfusion as an ancillary imaging tool, and more research studies are 
needed to establish the reliability of this technique in the clinical setting.
4. Conclusions
For clinical confirmation of brain death, the three essential criteria are apnea, 
absence of brain stem reflexes, and coma. In situations where brain death cannot 
be confirmed by one of these clinical tests or there are uncertainties around the 
reliability of clinical examination, ancillary imaging techniques are required to 
confirm brain death. We describe different ancillary imaging tests commonly used 
and reported to confirm the brain death. More research is required to validate these 
tests to become gold standards in the clinical practice.
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